Ozempic and Wegovy May Weaken Link Between Impulsivity and Violence
A recent study from Rutgers University suggests that patients prescribed glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic and Wegovy), may experience a reduction in impulsive and ... Read More